Efficacy of Sensi-IP Toothpaste in the Treatment of Dentinal Hypersensitivity Compared to a Sodium Fluoride Toothpaste

Inclusion Criteria: * Willing and able to abide by the terms of the consent form * Can independently sign informed consent * Participants 18-80 years old * Agree to abstain from any other desensitizing, (stannous fluoride, arginine, calcium phosphosilicate, nanohydroxy apatite, potassium nitrate and varieties) whitening or other dental procedures for the duration of the trial * Agree to refrain from all oral hygiene procedures (in addition to the Study Product) and chewing gum for 8 h prior to each scheduled visit and refrained from eating and drinking for 4 h prior to each visit (sips of water is allowed for taking routine medications). * Have at least two hypersensitive teeth (≥2 Schiff Airblast Sensitivity Score) consistent at screening and baseline. Target Teeth: 1. Demonstrate cervical dentin exposure, which may be visible with the use of loupes 2. Are non-adjacent in 2 different quadrants, anterior to the molars. Exclusion Criteria: * Are pregnant (to be confirmed by an over-the-counter dipstick pregnancy test) or breast feeding * Have lip or tongue piercing which the subject is unwilling to remove for the duration of the study * Have an active oral ulcer (Aphthous ulcer) at the time of screening * Have undergone desensitizing treatment (stannous fluoride, arginine, calcium phosphosilicate, nanohydroxy apatite, potassium nitrate and varieties) within the 1 month preceding the screening visit * Have undergone tooth bleaching within 8 weeks of screening * Have undergone scale, polish, interventional dental procedures within 1 month of screening * Are currently undergoing orthodontics * Receiving concomitant medication/therapy that might affect dentine hypersensitivity, e.g., regular use (\>3X per week) of analgesics, antihistamines, non-steroidal anti-inflammatory drug, and selective serotonin reuptake inhibitor medication * Demonstrate severe bruxism as indicated by reported muscular pain * Reduced salivary flow as determined by clinical assessment and/or patient report, diagnosed with Sjogren's disease, received radiation therapy to the head or neck within a year or currently being on medications that may cause xerostomia * Have generalized gingivitis or active periodontal disease as determined by the clinical exam or undergoing treatment for the above disease * Have had gingival surgery in the previous six months * Have allergies to any Study toothpaste ingredients, including the flavor components * With active caries or any condition such as pulpitis that would precipitate mouth pain * Who have self-reported eating disorders, uncontrolled gastroesophageal reflux disease (GERD or Acid Reflux), excessive dietary or environmental exposure to acids, or other systemic conditions that are predisposing to dentinal hypersensitivity * Participated in other clinical trials in the previous 28 days * Have smoked/vaped or used marijuana in the previous 12 months * Are diagnosed with unstable mental illness or chronic pain (e.g., fibromyalgia, TMD, migraine, etc.) that could alter the Participant's ability to report pain accurately * In the opinion of the Investigator, are unable to comply fully with the trial requirements Target Teeth With: 1. Extensive or unsatisfactory restorations fractures, periodontal alterations, caries lesions, orthodontic brackets, endodontic treatments, or pulp alterations interfering confounding evaluations 2. Crowns, veneers, or bridges